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Abstract
Background: Current Uganda National Malaria treatment guidelines recommend parasitological confirmation either
by microscopy or rapid diagnostic test (RDT) before treatment with artemether-lumefantrine (AL). However, the
cost-effectiveness of these strategies has not been assessed at rural operational primary care centres.
Methods: Three health centres (HCs) were randomized to three diagnostic arms (microscopy, RDT and
presumptive diagnosis) in a district of low and another of high malaria transmission intensities in Uganda. Some
22,052 patients presenting with fever at outpatients departments were enrolled from March 2010 to February 2011.
Of these, a random sample of 1,627 was selected to measure additional socio-economic characteristics. Costing
was performed following the standard step-down cost allocation and the ingredients approach. Effectiveness was
measured as the number and proportion of patients correctly diagnosed and treated. Incremental Cost-
Effectiveness Ratios (ICERs) were estimated from the societal perspective (http://Clinicaltrials.gov, NCT00565071).
Results: Overall RDT was most cost-effective with lowest ICER US$5.0 compared to microscopy US$9.61 per case
correctly diagnosed and treated. In the high transmission setting, ICER was US$4.38 for RDT and US$12.98 for
microscopy. The corresponding ICERs in the low transmission setting were US$5.85 and US$7.63 respectively. The
difference in ICERs between RDT and microscopy was greater in the high transmission area (US$8.9) than in low
transmission setting (US$1.78). At a willingness to pay of US$2.8, RDT remained cost effective up to a threshold
value of the cost of treatment of US$4.7.
Conclusion: RDT was cost effective in both low and high transmission settings. With a global campaign to reduce
the costs of AL and RDT, the Malaria Control Programme and stakeholders need a strategy for malaria diagnosis
because as the cost of AL decreases, presumptive treatment is likely to become more attractive.
Background
The replacement of conventional anti-malarial drugs
with artemisinin-based combination therapy (ACT) for
treatment of uncomplicated malaria stimulated the
interest in reassessing the diagnostic practices in
malaria-endemic countries in sub-Saharan Africa [1-3].
Clinical (presumptive) diagnosis of malaria, the current
diagnostic strategy in remote settings leads to
considerable drug expenditure [4,5] on inappropriate
treatment of non-parasitaemic patients [6-8]. The World
Health Organization and the Uganda national guidelines
[9,10] recommend parasitological confirmation of
malaria either by microscopy or rapid diagnostic tests
(RDT) before treatment is started.
In rural health centres (HCs) routine malaria micro-
scopy if available, is often of limited quality [11,12]. In
view of the limitations of microscopy, Uganda com-
menced the rollout of malaria RDTs (primarily histi-
dine-rich protein II [HRP2] based tests) in parish and
sub-county level HCs with no laboratory infrastructure,
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as a means of targeting ACT use. The rollout was
phased commencing with six districts in 2008. The exer-
cise is however stalled due to stock-out of RDTs from
end of 2009. With availability of RDTs, scaling up is
planned to an additional 22 districts. Currently, there
are 112 districts in the country.
There is considerable debate regarding the cost-effec-
tiveness of routine use of RDTs as an integral part of
deploying ACTs. On the one hand, some studies con-
ducted elsewhere reported that replacement of malaria
microscopy with RDTs would increase the provider
costs [2,13]. On the other hand, relative to microscopy,
the use of RDTs was likely to be cost-effective [3,14-16].
In the face of the dynamic market, this debate necessi-
tated an empirical economic evaluation of the available
malaria diagnostic techniques in the local setting. The
current study assessed the cost effectiveness of treating
malaria with artemether-lumefantrine (AL) based on
microscopy, RDT or presumptive diagnosis at sub-
county public HCs from the societal perspective.
Methods
Study setting
The study was carried out in six sub-county level gov-
ernment HCs, three in Bushenyi and three in Iganga
districts of Uganda. Bushenyi district is located in
south-western Uganda, 310 km from the capital city
Kampala. HCs in Bushenyi are located at an altitude of
1,744-1,962 m above sea level. The climate is relatively
wet with annual rainfall of 800-2,000 mm, and annual
temperature range of 12.5°-30°C. The substantial part of
Bushenyi is of hilly-rough and rugged terrain with the
topography dominated by undulating hills. Iganga dis-
trict is located in eastern Uganda. The land surface is
mainly flat. HCs in Iganga are located at an altitude of
1,059-1,119 m above sea level. The temperatures range
from 23°-27°C with annual rainfall of 900-1,200 mm.
The Uganda government categorizes Bushenyi as low
and Iganga as high malaria transmission intensity set-
tings. Since 2001, patients do not pay for medical ser-
vices at public HCs. Bushenyi and Iganga were not
among the districts in the first phase of RDT rollout.
However, RDTs were introduced in the “RDT arm” by
this trial in 2007. Additional description of the study
setting was published elsewhere [17].
Study design and population
The study was a randomized cost-effectiveness trial
(http://Clinicaltrials.gov: NCT00565071). In each district,
HCs were randomized to three diagnostic arms (micro-
scopy, RDT and presumptive diagnosis). The study
population included HC clinical and laboratory staff and
all outpatients presenting with fever (by statement or
measured axillary temperature ≥37.5°C). Of these, a
random sample of 1,627 outpatients was chosen to mea-
sure selected socio-economic data. The study was inte-
grated within the existing district health services
delivery system to reflect the real-life operational
conditions.
Laboratory procedures
The detailed description of the laboratory procedures
and subsequently the performance (sensitivity and speci-
ficity) of the three diagnostic strategies has been pub-
lished [12]. Briefly, finger-prick blood specimens were
drawn from a sample of 300 outpatients attending HCs
stated above. They were then processed following stan-
dard operating procedures. The validity indicators were
gauged against polymerase chain reaction as reference
standard.
Collection of cost data
Cost data was categorized into internal costs (public
provider costs) and external costs (patient costs). Data
were collected from March 2010 to February 2011 as
detailed below.
Collection of internal costs
Real-life facility cost data were collected covering a per-
iod of 12 months in which 22,052 malaria visits were
made. The data included recurrent costs (personnel, sta-
tionery, utilities, medicines, clinical and laboratory sup-
plies) and capital costs (buildings, equipment and
furniture). Financial reports were reviewed and inter-
views were conducted with staff to ascertain additional
resources used such as the primary health care funds
and those likely to be donations. Costs were collected in
Uganda shillings (Ush) and converted to US dollars
(exchange rate US$1 = Ush2,380, February 3rd 2011).
Health centre personnel costs
The effective contact time with those seeking care was
one of the main input parameters for personnel costs.
Contact time was recorded for a random sample of
1,627 outpatients. When a patient arrived at the HC,
time was recorded by the research assistant on a “time
sheet.” The “time sheet” was then given to the patient.
Thereafter, the time was recorded by clinicians and
laboratory personnel for every service provided. The
“time sheet” was finally retained at the dispensing win-
dow. For the laboratory personnel, the effective contact
time was comprised of: drawing a sample from the
patient, slide preparation, scanning the 200 film fields
until declaring a slide negative and reporting of results.
With regard to RDT, effective contact time was com-
prised of: drawing blood samples from patients, applying
samples onto the test, test reading and reporting of
results. The outpatient clinics at sub-county HCs run
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for eight hours from Monday to Saturday and about five
hours on Sunday. Therefore, HC staff work 68 hours
(4,080 minutes) weekly. Assuming a year of 52 weeks;
HC staff work 48 weeks, less four weeks of annual leave.
The HC staff were also interviewed regarding their time
allocation for other services. The time used for adminis-
tration was documented separately by the research assis-
tants based at the HCs. Personnel monthly salaries were
recorded from their pay-slips.
Drugs, laboratory supplies and RDT
Artemether-lumefantrine was costed as it is distributed
in four different fixed-dose weight-specific packs (35 kg
and above, 25-34.9 kg, 15-24.9 kg and 5-14.9 kg). The
costing of non-malaria treatment was based on “per
tablet” or “per capsule” of prescribed drugs to make up
a dose in each of the weight categories. All laboratory
supplies used for the 12 months were documented. The
cost of RDT (Paracheck, Orchid Biomedical Systems,
Goa, India) was US$0.84 as per Joint Medical Stores
price catalogue. Medicines and supplies used were
recorded from primary source documents including dis-
pensary records, outpatient registers, laboratory records
and stock cards. The cost of medicines and supplies
were obtained from Uganda National Medical Stores
and Joint Medical Stores delivery reports kept at the
HCs. Medicines and disposables that were supplied but
not used during the study period were excluded.
Utilities and stationery
Utilities mainly included coffee/tea for staff, water and
fuel for lighting. None of the six HCs had electricity at
the time of implementation of this study. The water
source was either bore-hole or rain-harvested. The
quantity of water used per week in litres was annualized
and converted into National Water and Sewerage Cor-
poration (NWSC) units. Costing of water was performed
basing on NWSC institutional/government rate [18].
The costs of fuel, sugar and coffee/tea were obtained
from receipts and HC reports. The health management
information system registers, laboratory registers and
stock cards were mainly supplied by National Medical
Stores and the costs were obtained from delivery
reports. The costs of additional stationery purchased
were estimated from market prices.
Capital costs
Capital goods were those items with a useful lifespan of
more than one year (buildings, equipment and furni-
ture). Inventories of capital goods were generated and
grouped within their locations (rooms) in the HC. HC
building plans were obtained from the district engineers’
office to determine the construction costs and relative
contribution of area coverage to outpatient case
management. The costs of renovations and repairs (if
any) within the 12 months of the study were also
collected.
Collection of patient (external) costs
Patient costs were episode-related expenditures. A sam-
ple of 1,627 outpatients was enrolled for collection of
external costs. On arrival at the HC, the time was
recorded on a “time sheet” but patients were also asked
to state the estimated time of departure from home.
Patients were systematically tracked until departure
from the HC. The aim of tracking patients was to esti-
mate the time spent accessing services. Exit interviews
were carried out and information recorded on study
questionnaire. The patient travel time was equal to arri-
val time minus the estimated time of departure from
home. It was assumed that patients used a similar time
for the return journey. The duration of interviews (in
minutes) was eliminated during analysis. Patient costs
were categorized into direct (out-of-pocket expenses on
transport and other incidentals related to treatment
seeking) and indirect (lost income due to medical care
seeking, including travel and waiting time). Direct
patient costs were valued according to reported expendi-
tures. Because majority of the patients were rural and
mainly peasants, lost earnings due to care-seeking were
valued using the Uganda Ministry of Public Service
minimum wage “for unskilled labour” salary scale U8
“entry point for support staff mainly attendants” which
is approximately US$55.9 per month employing stan-
dard methods [19].
Valuation of resource use and unit cost of diagnosis for
each outpatient visit
The unit cost of diagnosis for each outpatient visit in
each arm was determined following a standard step-
down cost allocation method [20,21] of all available HC
resources. The ingredients technique was also employed
and provided data directly measured for example “ser-
vice provider effective contact time” with patients, quan-
tity and costs of drugs and supplies used. Further, the
annualized values of buildings, furniture and equipment
were estimated using a standard procedure [21] assum-
ing a useful lifespan for these goods of 30, 10 and seven
years respectively and with a discount rate of 3%. Three
major cost centres (overhead, support and the final ser-
vices) were identified. Resources (Table 1) were allo-
cated in three steps separately for each HC and later
aggregated. In the first step, the total cost of running
each HC were allocated to the three cost centres. Per-
sonnel salaries were allocated using the measured staff
time. Laboratory supplies, cleaning materials, drugs and
disposables were proportioned or fully allocated to the
relevant cost centres. Capital costs and stationery were
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allocated basing on actual or estimated use. In the sec-
ond step, overhead costs were allocated to the support
and final services centre. In the third step, the total
costs of running a HC were subsequently allocated to
the level performing the individual final services, such as
the outpatient department (OPD) using an allocation
criterion that reflected the actual resources used. The
total costs of running an OPD were divided by the num-
ber of final services to arrive at the unit cost per service
with and without parasitological confirmation of
malaria.
The cost effectiveness analysis (CEA) model
In order to determine the cost effectiveness, a decision
tree in TreeAge was used with a patient cohort present-
ing at the outpatient department of a rural HC. Patients
entered the model at the time when the attending clini-
cians suspected uncomplicated malaria. Once in the
model, patients were investigated using microscopy,
RDT or presumptive diagnosis. Effectiveness values of
the strategies (Table 2) and costs of treating an
outpatient (provider and patient costs combined) were
used to populate the model. Because there is normally
over prescription of analgesics, it was assumed that a
true parasitaemic patient getting AL was also likely to
get an analgesic. It was also assumed that a patient with
negative test result got antibiotic and analgesic
treatments.
Statistical analysis
Data was double-entered and validated in EpiData ver-
sion 3.1 software (The EpiData Association, Odense,
Denmark) and analysed in Stata version 10 (Stata Corp,
College Station, Tx, USA), TreeAge and MS-Excel.
STATA was mainly used in the descriptive analysis.
Excel was used in costing especially Step-down account-
ing. TreeAge was used for constructing and analysing
the decision tree and uncertainty in the cost-effective-
ness model. The p-values were calculated at the 0.05
level of significance and Confidence Interval (CI) was
set at 95%.
Sensitivity analysis
Sensitivity analysis was conducted in TreeAge on the
variables that were uncertain and prone to change over
time. These included prevalence of malaria, costs of
RDT and AL. Sensitivity and specificity [12] were also
examined. The cost of AL and RDT were halved and
doubled to get the lower and upper limits of the interval
respectively.
Outcome measures
The primary endpoints were: 1) effectiveness measured
as the number and proportion of patients correctly diag-
nosed (true positive + true negative) and treated; and 2)
incremental cost per additional case correctly diagnosed
and treated (incremental cost effectiveness ratio - ICER)
Table 1 Aggregate resources (US$) at two health centres per arm and allocation criteria
Recurrent costs Presumptive RDT Microscopy Allocation criteria
Salaries 24955 28374 40001§ Measured staff time
Drugs and disposables 13757 14177 18521 To relevant cost centre
Stationery 311 393 432 Estimated use
Utilities 459 393 565 Relative to size of space
Laboratory and RDT supplies N/A 4221 1874 To relevant cost centre
Cleaning materials 340 306 331 To relevant cost centre
Capital costs*
Building** 3749 5973 7497 Actual use
Equipment 402 498 767 Actual use
Furniture 144 149 216 Actual use
Total 44,117 54,484 70,204
N/A = not applicable, RDT = rapid diagnostic test
§includes salaries of laboratory personnel
*goods with useful lifespan of more than one year, costs annualised at 3% discount rate
** includes sits in the waiting area made of fixed concrete
Table 2 Comparison of effectiveness of the three
diagnostic strategies
Test resultsψ Diagnostic strategy
Presumptive Microscopy RDT
True positivea 35 42 81
False positive 53 14 29
False negative 54 47 8
True negativeb 158 197 182
Totalc 300 300 300
Number correctly diagnosedd 193 239 263
Proportion correctly diagnosed (%)e 64.3 79.7 87.7
ψgauged against polymerase chain reaction as reference standard, RDT =
rapid diagnostic test, d = (a+b), e = (d/c)*100
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defined as the change in costs over the change in effec-
tiveness of moving from the presumptive strategy (the
base case) to the next best alternative.
Ethical approval
The study was approved by Makerere University School
of Public Health Higher Degrees Research and Ethics
Committee; and the Uganda National Council for Science
and Technology (Ref: HS 209). The study was registered
with the http://Clinicaltrials.gov (NCT00565071).
Results
Effectiveness of the three diagnostic strategies
Effectiveness of each diagnostic strategy was calculated
based on a recent publication [12] from the same trial
preceding this paper. Malaria RDT was the most effec-
tive with the number of cases correctly diagnosed and
treated being 263, followed by microscopy: 239 and pre-
sumptive diagnosis: 193 (Table 2). The corresponding
proportions of patients correctly diagnosed and treated
were 87.7%, 79.7% and 64.3% respectively. Routine use
of RDT or microscopy would result into an additional
36.3% and 23.8% respectively of patients correctly diag-
nosed and treated in comparison to the presumptive
technique.
In the high transmission area, effectiveness values
were: RDT 86.0%, microscopy 70.7% and presumptive
diagnosis 59.3%. The corresponding effectiveness values
in the low transmission setting were 89.3%, 88.7% and
69.3% respectively.
Analysis of internal costs
The unit cost of diagnosis in United States dollars (US$) in
each arm was determined using the number of final ser-
vices in the outpatient department. Overall, 22,052 malaria
visits were made over the 12 months of data collection
period. The costs for each strategy were allocated using
the step-down technique to the level of an individual
attending the OPD. The cost analysis for each strategy is
presented in Table 3 and briefly described as follows:
The presumptive strategy
The overall cost allocation for the outpatient services in
the presumptive arm was US$18,807 (Table 3). There
was no parasitological confirmation of malaria in this
arm. Therefore, the total allocation for clinical diagnosis
of malaria was equal to the total for malaria manage-
ment in the OPD (US$10,242) minus that of drugs and
disposables (US$3,762) which was equal to US$6,480.
The aggregate number of malaria visits in the two HCs
constituting the presumptive arm was 10,446. Therefore,
the unit cost of presumptive diagnosis was US$6,480/
10,446 which is equal to US$0.62.
Rapid diagnostic test strategy (RDT)
In the RDT arm, the total cost of running an OPD was
US$25,437 (Table 3). Out of this, US$12,100 (47.6%)
was allocated to management of malaria, of which US
$5,227 was for diagnostic services. The cost of RDTs
was the major determinant constituting 74.6% of the
amount allocated to diagnostic services. The aggregate
number of malaria RDTs performed in the two HCs in
this arm was 4,039. Therefore, the unit cost of diagnosis
was US$1.29, which was lower than that for HC
microscopy.
The microscopy strategy
The total cost of running an OPD was US$31,759, with
US$16,553 (52.1%) allocated to malaria management of
which US$9,515 (57.5%) was to diagnostic services.
Laboratory supplies and equipment accounted for 17.9%
while salary constituted 56.7% of the diagnostic services.
The number of malaria investigations done over the per-
iod of study was 6,219 giving a unit cost of diagnosis of
US$1.53.
Drug costs
The unit cost of AL fixed-dose weight-specific pack
decreased with the weight of the patient. However, the
average cost of AL dose was US$1.38. The average
cost of antibiotic/analgesic dose was US$1.05 and the
pattern across the weight-specific groups was similar
to that of AL.
Table 3 Aggregate and unit cost of diagnosis by diagnostic strategy (US$)
Presumptive Microscopy RDT
Total cost allocation for OPD services 18807 31759 25437
Number of final services at OPD 20103 24864 18480
Total cost allocation for management of malaria at OPD 10242 16553 8512
Number of OPD malaria visits made in the 12 monthsa 10446 7560 4046
Total cost allocation for OPD malaria diagnostic servicesb 6480 9515 5227
Number of OPD malaria tests donec N/A 6219 4039
Unit cost per malaria testd N/A 1.53 1.29
Unit cost of presumptive diagnosise 0.62 N/A N/A
RDT = rapid diagnostic test, OPD = outpatient department, N/A = not applicable, d = (b/c), e = (b/a)
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External costs (patient costs)
In public HCs, patients do not pay for medical services.
Therefore, patient costs relate to direct out-of-pocket
expense on the episode prior to visiting the HC, trans-
port and other non-medical incidentals (external direct
costs); and the indirect cost of travel and waiting time
(external indirect costs).
External indirect costs
The mean distance from home to the HC was 5.7 km
[5%CI: 2.9-8.4]. Overall, HC staff in the presumptive
arm tended to report to work in late morning after
patients had arrived resulting into an extended visiting
time. The mean travel time was 139.5 minutes [95%CI:
131.1-147.9], but was not different between arms (Table
4). The time spent accessing services when using RDT
134.4 minutes [95%CI: 123.5-145.3] was not different
from that of presumptive treatment, but significantly
shorter than that of microscopy 188.5 minutes [95%CI:
173.8-203.3]. The travel time and the overall time for
the HC visit were converted into a single monetary
measure “opportunity cost.” This implies that on aver-
age, the time cost due to absence from work as a result
of suffering from suspected or confirmed malaria was
US$1.59. The time cost with subsequent loss of income
was likely to be greater in the microscopy arm (US
$1.68) compared to RDT US$1.45, p < 0.001, or pre-
sumptive-based treatment US$0.80, p = 0.005 because
the time taken to diagnose a case and produce results
was much longer in the microscopy arm.
External direct costs
The mean monthly household income was US$19.8
[95%CI: 15.0-24.5] (Table 4), and was similar in the
three arms. The mean expenditure on treating the epi-
sode prior to visiting the study HC was US$0.40 [95%
CI: 0.34-0.46], still not significantly different between
the study arms. Patients in the low transmission setting
significantly incurred direct expense on transport US
$0.65 [95%CI: 0.55-0.76], compared to those in the high
transmission area US$0.31 [95%CI: 0.23-0.38]. Expendi-
ture on transport was not significantly different between
arms. The mean supplementary non-medical out-of-
pocket expenditure during the HC visit was US$0.2.
Treatment cost from the societal perspective
The total cost of treatment of an outpatient with sus-
pected or confirmed malaria was comprised of the cost
of diagnosis, drugs dispensed and patient costs. The unit
cost of treatment was cheapest in the presumptive arm
(Table 5), followed by that in the RDT arm while micro-
scopy was the most expensive.
Determining the incremental cost effectiveness ratio
(ICER)
Using the unit cost per patient correctly diagnosed and
treated compared with the effectiveness of each strategy,
overall RDT was the most cost effective (Figure 1) with
the lowest ICER US$5.0 compared to microscopy US
$9.61 (Table 6). In the high transmission setting, the
ICER was US$4.38 for RDT and US$12.98 for micro-
scopy. The corresponding ICERs in the low transmission
setting were US$5.85 for RDT and US$7.63 for micro-
scopy respectively. The difference in ICERs between
RDT and microscopy was greater in the high transmis-
sion setting (US$8.9) than in the low transmission area
(US$1.78).
Sensitivity analysis
Overall, a reduction in the cost of AL and RDT was
associated with improvement in the cost effectiveness of
RDT and microscopy. An increase in malaria prevalence
was associated with an improvement in the cost effec-
tiveness of RDT. At a willingness to pay of US$2.8, the
RDT remained cost effective up to a threshold value of
the cost of treatment of US$4.7.
Discussion
Following the change in the malaria treatment policy in
2005/2006, the Uganda government commenced the
rollout of RDTs in 2008 to target AL to only parasitae-
mic patients. However, as the health system has
struggled with stock-out of RDTs since 2009, the price
of AL has decreased from US$2.4 in the year 2004/2005
Table 4 Mean direct expenditure and lost income while seeking care (US$) at government health centres
Variable Overall
Mean[95%CI]
Presumptive
Mean[95%CI]
RDT
Mean[95%CI]
Microscopy
Mean[95%CI]
Monthly household income 19.8[15.0-24.5] 21.4[11-31.8] 16.5[9.4-23.6] 21.3[14.9-27.7]
Medication prior to visiting HC 0.40[0.34-0.46] 0.44[0.32-0.56] 0.40[0.27-0.52] 0.34[0.30-0.44]
Expense on transport 0.43[0.35-0.50] 0.43[0.18-0.69] 0.39[0.26-0.52] 0.44[0.34-0.54]
Out-of-pocket (other non-medical) expense 0.20[0.11-0.29] 0.30[0.06-0.66] 0.13[0.03-0.22] 0.23[0.12-0.34]
Opportunity cost (travel and waiting) 1.59[1.53-1.66] 0.80[0.71-0.94]* 1.45[1.35-1.50] 1.68[1.57-1.79]
*only travel time converted into money, CI = Confidence Interval, HC = health centre, RDT = rapid diagnostic test
Batwala et al. Malaria Journal 2011, 10:372
http://www.malariajournal.com/content/10/1/372
Page 6 of 9
[2,3,15,16,22,23] to the current average of US$1.38 due
to the global campaign to reduce costs and presence of
generic products in the market. It was therefore impera-
tive to institute an empirical economic evaluation of the
three malaria diagnostic strategies in remote primary
care centres in a health system where patients do not
pay for medical services.
It is reported here that diagnosing malaria based on
signs and symptoms alone (presumptive diagnosis) had
the lowest cost (US$0.62). The clinician time was a
major recurrent input that determined the cost of pre-
sumptive diagnosis. However, the effective clinician con-
tact time was similar in the three arms. Also, the unit
cost of outpatient treatment was lowest in the presump-
tive arm whether the patient got AL alone or in combi-
nation with antibiotics. In this analysis, the presumptive
method was the base-case because documentation of
fever or history of fever has traditionally been consid-
ered sufficient evidence for prescribing anti-malarial
therapy in rural primary level HCs in Uganda as else-
where in sub-Saharan Africa. Even when microscopy is
available, not all patients get the service, yet clinicians
often prescribe anti-malarial treatment to persons with
negative microscopy results [7,24,25]. Presumptive diag-
nosis was the least effective. However, effectiveness of
all methods was inversely related to transmission inten-
sity. This observation was also reported in Tanzania [2].
Overall, the RDT technique was the most effective.
This finding is supported by comparable studies carried
out in other settings [2,15,16], although effectiveness in
these studies was determined against microscopy as
reference standard. An earlier publication [12] from the
current trial reported that expert microscopy “would be
gold standard” performed poorly. Here, effectiveness is
defined as the proportion of patients correctly diagnosed
(true positive + true negative) and treated. Use of expert
microscopy as gold standard would erroneously increase
the sensitivity and specificity resulting into high effec-
tiveness values. In the current paper therefore, effective-
ness was determined with PCR as the reference
standard.
The major parameter that determined the cost of
RDT-based patient management was cost of the test
supplemented by the personnel cost for giving the ser-
vice. The current price of RDT (US$0.84) at point of
use is still high, although it has decreased over time.
Table 5 Unit cost of outpatient treatment by diagnostic arm (US$)
Cost category Presumptive RDT Microscopy
Unit cost of diagnosisa 0.62 1.29 1.53
Mean cost of AL only per visitb 1.38 1.38 1.38
Mean cost of antibiotics/analgesics per visitc 1.05 1.05 1.05
Patient costs per visit (mean)d 1.97 2.37 2.69
Unit cost of OPD treatment visit with AL onlye 3.97 5.04 5.60
Unit cost of OPD treatment visit with AL+antibiotic/analgesicf 5.02 6.09 6.65
Unit cost of OPD treatment visit with antibiotic/analgesicg 3.64 4.71 5.27
AL = artemether-lumefantrine, OPD = outpatient department, RDT = rapid diagnostic test, e = (a+b+d), f = (a+b+c+d), g = (a+c+d)
Figure 1 Cost effectiveness of three malaria diagnostic strategies.
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Previous reports have used RDT costs ranging from US
$1.30 to US$1.50 [15,16]. In the current paper, the use
of RDT increased the cost of diagnosis by US$ 0.67
(about 108% increase) in comparison with the presump-
tive technique. An increase in provider cost with intro-
duction of RDTs as a diagnostic service was also
reported in Tanzania [2,13]. This increase is however
likely to be offset by its superior effectiveness if clini-
cians adhere to test results. The cost of radical drug
treatment normally occurred with all strategies. How-
ever, the unit cost of outpatient treatment visit was
lower than that of microscopy but higher than in the
presumptive method.
Microscopy was less effective compared to RDT. The
cost of microscopy diagnostic service was however
higher (US$1.53) than that of RDT (US$1.29). In malaria
microscopy, the major cost input was the personnel sal-
ary constituting 57.5% while laboratory supplies and
equipment constituted only 17.9% of the diagnostic ser-
vice. Laboratory-related capital costs (laboratory space,
equipment, etc) were additional costs which were not
inputs in the RDT or presumptive arms. This paper
focussed on the evaluation of the cost effectiveness of
the three strategies at point of care in rural settings. A
study in Thailand that extended the analysis to include
the pre-service training reported microscopy to be even
more expensive [26]. In the Thailand study, however,
the presumptive arm was non-existent while blood
smears were drawn from patients and transported to
static centres for microscopic investigations constraining
appropriate comparison with the current findings.
With regard to external costs, the opportunity cost of
travel was not significantly different between study
arms. The opportunity cost of waiting for treatments
especially test results was the major external indirect
cost more so in the microscopy arm. The direct cost of
transport was not different between study arms, but it
was significantly higher in the setting of low transmis-
sion due to the hilly difficult terrain. Overall, these
external costs were a major part of the unit cost per
patient correctly treated and on ICERs.
Few comparable empirical cost-effectiveness analyses
done in Africa were available at the time of writing this
paper. However, a full comparison with the current findings
was difficult. The study in Zambia [15] examined the cost
effectiveness of the three strategies from the narrow provi-
der perspective, and was carried out in sentinel sites, which
in reality did not represent typical rural HCs. In Tanzania
[2], the cost effectiveness of RDT was only compared to
microscopy, the presumptive arm was missing. In addition,
the study was performed in hospital settings where patient
volumes would not be comparable to those attending HCs.
On the other hand, in Nigeria [16], patients five years and
older paid for the medical services, which impacted on their
direct expenditure. Further, the Nigerian study used a dif-
ferent measure of effectiveness and patients were treated
with dihydroxy-artemisinin/piperaquine, while costing was
based on AL. At the time these studies were conducted, the
costs of AL and RDT were higher than the current rates.
However other than the study in Tanzania [2], all support
the current findings that RDT is the most cost effective.
In all scenarios in the sensitivity analysis, RDT main-
tained its superior cost effectiveness compared to pre-
sumptive diagnosis and microscopy. With the global
campaign to reduce the prices of ACT and RDTs, policy
makers need to re-think and make contingency plans
regarding malaria diagnosis. As the cost of AL decreases,
presumptive treatment is likely to become more attrac-
tive. This scenario is likely to mirror the era of chloro-
quine or chloroquine/sulphadoxine-pyrimethamine as
first-line drugs that were cheap. Therefore, with falling
prices of AL, measures need to be put in place to sensi-
tize the health service users about the benefits of appro-
priate malaria diagnosis and treatment.
Conclusion
RDT was the most cost effective. However, with the
reduction in the cost of RDT and AL, the Malaria Con-
trol Programme and stakeholders need a contingency
plan regarding malaria diagnosis. Further, there is need
to sensitize health service users about the benefits of
appropriate malaria diagnosis.
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